A new generation of engineering workflows aims to move beyond AI-assisted coding by enabling AI agents to build models, ...

Alibaba Group Holding’s latest artificial intelligence model has clinched a top-tier spot on a major global coding leaderboard, making the Chinese technology giant the only developer other than ...

Anthropic appears to be preparing for the public rollout of "Mythos," which was announced in April as a restricted model that poses major security risks to private and public software. On April 7, ...

Abstract: Simulink is widely used for the model-driven design of embedded systems. It is able to generate optimized embedded control software code through expression folding, variable reuse, etc.

Anyone can code using AI. But it might come with a hidden cost. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Over the past year, AI systems have ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

Microsoft Corp. aims to develop large, cutting-edge artificial intelligence models by next year, part of a push to build in-house alternatives to the most powerful AI tools from OpenAI and Anthropic. ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

It exposes Simulink context as deterministic, machine-readable tool outputs. It lets AI reason on real model topology/parameters instead of screenshots. It keeps workflows real-time and ...

The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across the entire tree of life, Evo 2 can identify patterns in gene sequences across ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...